Protocol No.: REMAIN-1-FRACTYL-HUB

REMAIN-1-FRACTYL-HUB: A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Pivotal Study to Assess the Efficacy of Revita® Duodenal Mucosal Resurfacing (DMR) on Body Weight Maintenance in Participants with Obesity and Who Have Achieved at Least 15% Weight Loss on Tirzepatide Obesity Pharmacotherapy (REMAIN-1)
Principal Investigator
Singh, Shailendra
Phase
NA
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Muhammad Soban Arif Maan
Student-research associate

View on ClinicalTrials.gov